{"id":31965,"date":"2025-04-17T19:53:56","date_gmt":"2025-04-17T11:53:56","guid":{"rendered":"https:\/\/flcube.com\/?p=31965"},"modified":"2025-04-17T19:53:57","modified_gmt":"2025-04-17T11:53:57","slug":"zhaoke-ophthalmology-signs-distribution-agreements-with-thailands-interpharma-for-myopia-and-presbyopia-treatments","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31965","title":{"rendered":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand’s Interpharma for Myopia and Presbyopia Treatments"},"content":{"rendered":"\n

China-based Zhaoke Ophthalmology Ltd (HKG: 6622<\/a>) has announced the signing of three distribution and supply agreements with Thailand’s Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.<\/p>\n\n\n\n

Product Portfolio and Terms<\/strong>
Under the terms of the agreements, Interpharma has secured exclusive rights to import, distribute, promote, market, and sell these products in Thailand. This includes responsibility for local regulatory filings. In return, Zhaoke will receive non-refundable, non-deductible advance payments and additional milestone payments tied to specific commercial achievements.<\/p>\n\n\n\n

Market Expansion and Impact<\/strong>
This strategic partnership marks a significant step in Zhaoke’s international expansion, particularly in the Southeast Asian market. By leveraging Interpharma’s local expertise, Zhaoke aims to enhance market penetration and provide Thai patients with access to innovative ophthalmic treatments.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply…<\/p>\n","protected":false},"author":1,"featured_media":31966,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[942,44,166],"class_list":["post-31965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hkg-6622","tag-ophthalmology","tag-zhaoke-ophthalmology"],"yoast_head":"\nZhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31965\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments\" \/>\n<meta property=\"og:description\" content=\"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31965\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T11:53:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-17T11:53:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand’s Interpharma for Myopia and Presbyopia Treatments\",\"datePublished\":\"2025-04-17T11:53:56+00:00\",\"dateModified\":\"2025-04-17T11:53:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965\"},\"wordCount\":169,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1708.webp\",\"keywords\":[\"HKG: 6622\",\"Ophthalmology\",\"Zhaoke Ophthalmology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31965#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31965\",\"name\":\"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1708.webp\",\"datePublished\":\"2025-04-17T11:53:56+00:00\",\"dateModified\":\"2025-04-17T11:53:57+00:00\",\"description\":\"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31965\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1708.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1708.webp\",\"width\":1080,\"height\":608,\"caption\":\"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31965#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand’s Interpharma for Myopia and Presbyopia Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments - Insight, China's Pharmaceutical Industry","description":"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31965","og_locale":"en_US","og_type":"article","og_title":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments","og_description":"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.","og_url":"https:\/\/flcube.com\/?p=31965","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-17T11:53:56+00:00","article_modified_time":"2025-04-17T11:53:57+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31965#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31965"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand’s Interpharma for Myopia and Presbyopia Treatments","datePublished":"2025-04-17T11:53:56+00:00","dateModified":"2025-04-17T11:53:57+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31965"},"wordCount":169,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31965#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","keywords":["HKG: 6622","Ophthalmology","Zhaoke Ophthalmology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31965#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31965","url":"https:\/\/flcube.com\/?p=31965","name":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31965#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31965#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","datePublished":"2025-04-17T11:53:56+00:00","dateModified":"2025-04-17T11:53:57+00:00","description":"China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the signing of three distribution and supply agreements with Thailand's Interpharma Public Company Limited. The agreements cover NVK002, a topical ophthalmic atropine solution for pediatric myopia progression; Brimochol PF, a presbyopia treatment; and six generic glaucoma medications, including bimatoprost, bimatoprost timolol, latanoprost, latanoprost timolol, travoprost, and travoprost timolol.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31965#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31965"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31965#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","width":1080,"height":608,"caption":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand's Interpharma for Myopia and Presbyopia Treatments"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31965#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Zhaoke Ophthalmology Signs Distribution Agreements with Thailand’s Interpharma for Myopia and Presbyopia Treatments"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1708.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31965"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31965\/revisions"}],"predecessor-version":[{"id":31967,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31965\/revisions\/31967"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31966"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}